Ghana vs Zimbabwe: HIV-positive TB patients on ART (antiretroviral therapy)
Ghana
96.0%
in 2024
Zimbabwe
96.0%
in 2024
Ghana rank
74th
Zimbabwe rank
74th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Ghana
- Zimbabwe
How they compare
Ghana currently reports 96.0% against 96.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2007 it was Zimbabwe ahead.
Ghana ranks 74th and Zimbabwe ranks 74th of 144 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | Ghana | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.7% | 29.7% | 8.0% | Zimbabwe |
| 2010s | 41.5% | 77.7% | 36.2% | Zimbabwe |
| 2020s | 95.4% | 94.4% | 1.0% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Ghana or Zimbabwe?
- Ghana, at 96.0% against 96.0% in Zimbabwe as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Ghana and Zimbabwe?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Zimbabwe?
- 18 years are reported by both, from 2007 to 2024.
- How do Ghana and Zimbabwe rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Ghana ranks 74th and Zimbabwe ranks 74th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.